Cargando…

Autistic traits and cognitive profiles of treatment-resistant schizophrenia()

The complex pathophysiology of treatment-resistant schizophrenia (TRS) includes severe positive symptoms but also other symptom domains. The overlapping psychological profiles of schizophrenia and autistic spectrum disorder (ASD) are not established. We compared TRS patients (n = 30) with schizophre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakata, Yusuke, Kanahara, Nobuhisa, Kimura, Atsushi, Niitsu, Tomihisa, Komatsu, Hideki, Oda, Yasunori, Ishikawa, Masatomo, Hasegawa, Tadashi, Kamata, Yu, Yamauchi, Atsushi, Inazumi, Kazuhiko, Kimura, Hiroshi, Iyo, Masaomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390750/ https://www.ncbi.nlm.nih.gov/pubmed/32760657 http://dx.doi.org/10.1016/j.scog.2020.100186

Ejemplares similares

Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia
por: Oishi, Kengo, et al.
Publicado: (2018)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012)

Increased Serum Levels of Oxytocin in ‘Treatment Resistant Depression in Adolescents (TRDIA)’ Group
por: Sasaki, Tsuyoshi, et al.
Publicado: (2016)

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2012)

Correction: Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2013)

Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia
por: Kanahara, Nobuhisa, et al.
Publicado: (2021)

Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
por: Oda, Yasunori, et al.
Publicado: (2015)

Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial
por: Hashimoto, Tasuku, et al.
Publicado: (2016)

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
por: Takase, Masayuki, et al.
Publicado: (2015)

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
por: Oda, Yasunori, et al.
Publicado: (2015)

Psychological Distress Symptoms Associated With Life Events in Patients With Bipolar Disorder: A Cross-Sectional Study
por: Sato, Aiko, et al.
Publicado: (2018)

Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study
por: Sasaki, Tsuyoshi, et al.
Publicado: (2014)

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2015)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study
por: Sasaki, Tsuyoshi, et al.
Publicado: (2014)

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
por: Hashimoto, Tasuku, et al.
Publicado: (2015)

Successful rechallenge with paliperidone after clozapine treatment for a patient with dopamine supersensitivity psychosis
por: Kobayashi, Remiko, et al.
Publicado: (2020)

Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases
por: Kanahara, Nobuhisa, et al.
Publicado: (2023)

Need for self-medication using over-the-counter psychoactive agents: A national survey in Japan
por: Shiina, Akihiro, et al.
Publicado: (2021)

First-episode psychosis in treatment-resistant schizophrenia: a cross-sectional study of a long-term follow-up cohort
por: Kanahara, Nobuhisa, et al.
Publicado: (2018)

Onset Pattern and Long-Term Prognosis in Schizophrenia: 10-Year Longitudinal Follow-Up Study
por: Kanahara, Nobuhisa, et al.
Publicado: (2013)

Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder
por: Tadokoro, Shigenori, et al.
Publicado: (2011)

Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report
por: Tadokoro, Shigenori, et al.
Publicado: (2017)

Strategy for treating selective serotonin reuptake inhibitor-resistant social anxiety disorder in the clinical setting: a randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatment
por: Yoshinaga, Naoki, et al.
Publicado: (2013)

Cyclothymic Temperament is Associated with Poor Medication Adherence and Disordered Eating in Type 2 Diabetes Patients: A Case–Control Study
por: Yamamoto, Tetsuya, et al.
Publicado: (2021)

Changes in Self-Regulation-Related Prefrontal Activities in Eating Disorders: A Near Infrared Spectroscopy Study
por: Sutoh, Chihiro, et al.
Publicado: (2013)

Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
por: Tadokoro, Shigenori, et al.
Publicado: (2012)

Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases
por: Muneoka, Katsumasa, et al.
Publicado: (2017)

Effect of educational intervention on attitudes toward the concept of criminal responsibility
por: Shiina, Akihiro, et al.
Publicado: (2017)

PS64. Psychiatrists' thinking about how to prescribe psychotropic drugs in out-patients with major depressive disorder and bipolar disorder in general clinical practice compared to the evidence-based guidelines.
por: Koseki, Maiko, et al.
Publicado: (2016)

Possible effect of blonanserin on gambling disorder: A clinical study protocol and a case report
por: Shiina, Akihiro, et al.
Publicado: (2021)

Relationship between perception and anxiety about COVID-19 infection and risk behaviors for spreading infection: A national survey in Japan
por: Shiina, Akihiro, et al.
Publicado: (2020)

Perception of and anxiety about COVID-19 infection and risk behaviors for spreading infection: an international comparison
por: Shiina, Akihiro, et al.
Publicado: (2021)

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2020)

Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [(11)C]CHIBA-1001 in Healthy Human Subjects
por: Ishikawa, Masatomo, et al.
Publicado: (2011)

Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2018)

Orengedoku-to augmentation in cases showing partial response to yokukan-san treatment: a case report and literature review of the evidence for use of these Kampo herbal formulae
por: Okamoto, Hideki, et al.
Publicado: (2013)

White Matter Features Associated With Autistic Traits in Obsessive-Compulsive Disorder
por: Kuno, Masaru, et al.
Publicado: (2018)

Health anxiety and healthcare costs in Japanese individuals: an Internet survey
por: Kobori, Osamu, et al.
Publicado: (2014)

Polydipsia and autistic traits in patients with schizophrenia spectrum disorders
por: Komatsu, Hiroshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7s6ckhn4bua0u4bhsbpnqt0gss